Toward a World that Works for Everyone
References
(https://goldenageofgaia.com/?p=331390)
. We want raw data, now. BMJ2009;339:b5405doi:10.1136/bmj.b5405.
. Why don’t we have all the evidence on oseltamivir?BMJ2009;339:b5351. doi:10.1136/bmj.b5351 pmid:19995815
. Complications: tracking down the data on oseltamivir. BMJ2009;339:b5387. doi:10.1136/bmj.b5387 pmid:19995818
. Neuraminidase inhibitors—the story behind the Cochrane review. BMJ2009;339:b5164. doi:10.1136/bmj.b5164 pmid:19995813
. The pioneers of transparency. BMJ2015;350:g7717. doi:10.1136/bmj.g7717 pmid:25555823
. From promises to policies: is big pharma delivering on transparency?BMJ2014;348:g1615. doi:10.1136/bmj.g1615 pmid:24574476